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Understanding Chest Pain: What Every
Psychologist Should Know
Steven M. Schwartz,13 Peter C. Trask,1 and Mark W. Ketterer2
Chest pain is one of the most frequent presenting complaints in Emergency
Rooms and other medical settings. A considerable number of these patients do
not have significant coronary artery disease. This led to plausible alternative
explanations for these presenting symptoms and these patients tend to have
unremarkable cardiac outcomes. Nevertheless, many studies have also docu-
mented that symptoms and related disability persist in the face of reassurances
about benign cardiac status. Given the implied threat of chest pain (e.g.,
myocardial infarction) and the presence of chest pain symptoms in other
noncardiac conditions (including anxiety and panic), it is not surprising
that many of these patients present with considerable emotional distress.
Consequently, chest pain symptoms represent diagnostic and treatment dilem-
mas for physicians and psychologists alike. The extent to which cardiac and
noncardiac factors contribute to all forms of chest pain remains unknown.
The function of this review is to provide mental health professionals with a
primer on relevant clinical issues in chronic chest pain. We examine several
common medical and psychiatric causes of chronic chest pain and selectively
review (1) the relevant medical and psychiatric diagnostic and treatment
considerations for chest pain and (2) the hypothetical biobehavioral mecha-
nisms relevant to psychological intervention, (3) while expanding on existing
conceptual models for understanding chest pain, and (4) offering some sug-
gestions for future research.
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INTRODUCTION
Chest pain is a frequent presenting complaint in many clinical settings
(Katon, 1990; Kroenke & Mangelsdorff, 1989) and may be indicative of a
number of clinically significant conditions including myocardial infarction,
embolus, empyema, angina pectoris, gastroesophageal dysfunction, panic,
and/or other forms of emotional distress (e.g., Alpert, Mukerji, Sabeti,
Russell, & Beitman, 1991; Alexander, Prabhu, Krishnamoorthy, & Halkatti,
1994; Beitman, Basha, Flaker, DeRosear, Mukerji, & Lamberti, 1987;
Beitman, Kushner, Basha, Lamberti, Mukerji, & Bartels, 1991a; Beitman,
Mukerji, Russell, & Grafing, 1993; Cannon, Camici, & Epstein 1992;
Fleet, Dupuis, Marchand, Burelle, & Beitman, 1994; Fleet, Dupuis,
Marchand, Burelle, & Beitman, 1997; Katon, Hall & Russo, 1988; Ketterer,
Brymer, Rhoads, Kraft, Kenyon, Foley, Lovallo, & Voight, 1996a;
Langevin & Castell, 1991; Lynch, Bakal, Whitelaw, & Fung, 1991; Medalie,
1990; Richter, 1991; Richter, Bradley, & Castell, 1989; Roy-Byrne,
Schmidt, Cannon, Diem, & Rubinow, 1989). Kroenke and Mangelsdorff
(1989) found chest pain to be the most frequent complaint in an ambulatory
care setting. About 7-10% of all patients presenting to the emergency room
have chest pain (American College of Emergency Physicians, 1995), making
this a significant clinical issue. Diagnostic procedures such as exercise stress
testing, thallium stress tests, and/or coronary angiography are useful in
identifying cases of coronary ischemia. However, it has been reported that
10-30% of those undergoing costly and invasive angiography have normal
or non-significantly obstructed coronary arteries (e.g., Dart, Davies, Dalai,
Ruttley, & Henderson, 1980; Kemp, Kronmal, Vlietstra, Frye, & The Coro-
nary Artery Surgery Study Participants, 1986; Kemp, Vokonas, Cohn, &
Gorlin, 1973; Lavey & Winkle, 1979; Papanicolaou, et al., 1986; Pasternak,
Thibault, Savoia, DeSanctis, & Hutter, 1980; Proudfit, Bruschke, & Sones,
1980). Studies have also found an unremarkable cardiovascular course for
these nonischemic chest pain cases (e.g., Bass, Wade, Hand, & Jackson,
1983; Beitman, 1992; Cannon, 1991; Lantinga, Sprafkin, McCroskery,
Baker, Warner, & Hill, 1988; Ockene, Shay, Alpert, Weiner, & Dalen,
1980; Papanicolaou et al., 1986; Richter, 1992; Swinson & Kuch, 1990;
Wielgosz, Flectch, McCants, Haney, & Williams, 1984). Nevertheless, many
of these studies also document continued symptoms and disability in pa-
tients even in the face of reassurances about their benign cardiovascular
status (Bass et al., 1983; Ockene et al., 1980; Papanicolaou et al., 1986;
Potts & Bass, 1993; Swinson & Kuch, 1990; Wielgosz et al., 1984). Because
many of these cases have primary or secondary psychiatric conditions rele-
vant to chest pain (e.g., Beitman, Mukerji, Lamberti, Schmid, DeRosear,
Kushner, Flaker, & Basha, 1989b; Costa, Zonderman & Engel, 1985; Elias,
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Robbins, Blow, Rice, & Edgecomb, 1982) and data support a biobehavioral
mechanism of causation, psychologists and other mental health profession-
als are likely to become increasingly involved in the care of these patients.
Identification and management of chest pain in all its forms remains
a complicated and underresearched area that demands increased attention.
The function of this review is to provide psychologists and other mental
health professionals with a concise primer on the relevant clinical issues in
chronic chest pain as they are currently understood. We examine several
common medical and psychiatric causes of chronic chest pain and selectively
review (1) the relevant psychiatric and medical diagnostic and treatment
considerations for chest pain and (2) the hypothetical biobehavioral mecha-
nisms relevant to psychological intervention, (3) while building on existing
conceptual models for understanding chest pain by offering a spectrum
approach to assessment and intervention using a chronic pain self-manage-
ment model, and (4) offering some suggestions for future research.
CHEST PAIN OF CARDIOVASCULAR ORIGIN
A number of cardiovascular conditions can produce chronic chest pain.
Only two (i.e., angina pectoris and microvascular angina) will be reviewed
here as most relevant to this literature. Angina pectoris (AP) results from
an imbalance between oxygen demand and supply to the heart muscle
secondary to significant buildup of atherosclerotic plaque in one or more
critical coronary arteries. Prognosis is most serious in cases where there is
considerable blockage of the left main coronary artery (because it feeds
the primary pumping portion of the heart), or when three or more of the
principal arteries are involved. Diagnosis of angina is complicated in that
symptoms can be vague and variable. Symptoms are sometimes painful, but
are more typically reported as "heavy," "pressured," or "tight" (Pantano,
1990). Angina pain can also be accompanied by dizziness, radiation of pain
down the arm, nausea, and/or vomiting. While discomfort is often localized
substernally, it can also occur in the back, at the base of the throat, or even
the jaw. In most cases pain is induced by physical exertion, but in some
cases pain or discomfort occurs at rest. Chest pain occurring at rest may be
indicative of coronary artery spasm ("Prinzmetal's angina"), microvascular
spasm (Cannon, 1991), or panic (Beitman, 1992).
Diagnostic procedures for angina include exercise stress testing, echo-
cardiogram, and cardiac catheterization. Exercise stress testing generally
focuses abnormalities in the ST segment of the electrocardiogram (i.e., that
segment that reflects the resting interval between heart beats) (Fisch, 1997;
VandenBelt, Ronon, & Bedynek, 1979; Scheldt, 1996). However, most
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episodes of chest pain are not accompanied by ST segment changes (Krantz,
Hedges, Gabbay, Klein, Falconer, Merz, Gottdiener, Lutz, & Rozanski,
1994). Use of the radioisotope thallium or technetium in stress testing is
diagnostically more sensitive and allows for imaging of myocardial perfu-
sion, volume, or wall motion. Identification of fixed or reversible "cold
spots" or wall motion abnormalities is indicative of diminished blood flow.
Treatments for AP essentially focus on providing the heart with more
oxygen or reducing the heart's oxygen demand. Medications such as nitrates
(e.g., nitroglycerine), angiotensin-converting enzyme (ACE) inhibitors, and
calcium channel blockers are used as vasodilators, designed to open up
narrowed coronary vessels so they better feed the heart muscle. Anticoagu-
lants (e.g., aspirin, Coumadin, Ticlid, Persantine) allow blood to pass more
freely through narrowed vessels by reducing blood viscosity. Beta blockers
and digoxin are used to reduce the heart's work load by slowing down its
activity and reducing its oxygen demand. Antilipidemic agents are also
used to slow the rate of obstruction by reducing blood-based lipids (Roberts,
1996). Angioplasty ("percutaneous transluminal coronary angioplasty,"
PTCA) opens blocked vessels mechanistically by inflating a specialized
catheter at the point of occlusion and spreading the plague thinly over the
vessel wall. Unfortunately 30-35% of patients redevelop clinically signifi-
cant blockage within 3-6 months (Scheidt, 1996). In some cases, stents (i.e.,
wire mesh structures) are inserted into the affected segment of the artery
via catheterization to help hold the vessel open and reduce the likelihood
of restenosis (Fischman et al., 1994).
Of particular interest to psychologists is the fact that emotional distress
can provoke ischemia-induced pain and ischemia in the absence of pain
(i.e., silent ischemia). For example, Goldberg et al. (1996) recently demon-
strated that mental stress alters a variety of cardiac functions (ejection
fraction, myocardial ischemia, vascular resistance). Blumenthal et al. (1995)
demonstrated a unique relationship between laboratory-induced ischemia
(i.e., mental stress) and ambulatory ischemia monitored in vivo. Most re-
cently, Kamarck, Shiffman, Smithline, Goodie, Paty, Gnys, and Yi-Kuan
Jong (1998) demonstrated elevated blood pressure and heart rate during
daily stress.
Given that mental events can alter cardiac functioning and are also
related to pain perception, psychological variables also bear on clinical
outcomes in AP patients (e.g., Allison, Williams, Miller, Patten, Bailey,
Squires, & Gau, 1995; Raines, Imeson, & Meade, 1987; Medalie, 1990).
Razin (1984) reviewed the psychological and behavioral factors relevant
to angina pectoris and the psychotherapeutic literature available at that
time. Razin concluded then that there were too few strong empirical studies
available to endorse a definitive conclusion on efficacy, but limited reports
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led Razin to believe that biofeedback and cognitive/behavioral therapies
held the most promise. Since that time a number of additional studies have
been published (e.g., Amarosa-Tupler, Tapp, & Carida, 1989; Payne et al.,
1994; Turner, Linden, van der Wai, & Schamberger, 1995) examining the
effects of relaxation, imagery, and cognitive restructuring on chest pain
and support the promise identified by Razin. However, like Razin, a more
recent review by Lewin (1997) concluded that there were still too few
comprehensive treatment studies to support conclusive efficacy.
Microvascular angina (MVA) is a term offered by Cannon and Epstein
(1988) to reflect more accurately the presumed underlying pathophysiology
of another form of cardiovascular chest pain (i.e., vasospasm of the coronary
microvasculature) (Cannon, 1991; Cannon et al., 1992). Studies of coronary
flow reserve (i.e., the ability of the microvasculature to dilate) have indi-
cated limited reserve in some chest pain patients during exercise (Cannon,
1983; Opherk, Zebe, Weihe, Mall, Durr, Graven, Mehmel, Schwarz, &
Kubler, 1981), although the various causal mechanisms (e.g., dysfunctional
sympathetic stimulation of the heart, cardiac-specific chest pain sensitivity,
or abnormal nociception) are largely hypothetical. While microvascular
angina has some of the features of true angina, it is partially differentiated
by the experience of chest pain at rest, more severe and prolonged pain,
and a poor response to antiischemic medications like nitrates (Cannon,
Watson, Rosing, & Epstein, 1983).
GASTROESOPHAGEAL DYSFUNCTION
It is estimated that approximately 35% of individuals who present
complaining of chest pain with normal coronary arteries have esophageal
abnormalities (DeMeester et al., 1982). Several specific gastroesophageal
(GE) disorders have been hypothesized to result in chest pain including
(1) diffuse esophageal spasm, (2) nutcracker esophagus, and (3) achalasia.
Gastroesophageal chest pain has been hypothesized to result from either
stimulation of mechanoreceptors (via spasm or distention) or chemorecep-
tors (via acid or bile) (Richter et al., 1989). The relationship between
spasms and esophageal pain is inconsistent and not necessarily diagnostic,
as contractions can be produced during times of stress in normal individuals
without report of pain (Robinson, Orr, McCallum, & Nardi, 1987). Like-
wise, nutcracker esophagus, which is characterized by peristaltic contrac-
tions of high amplitude, does not necessarily produce chest pain. Studies
have also failed to report a reduction in contractions when chest pain has
been relieved (Richter et al., 1987), suggesting that there may be no causal
relationship between peristaltic contractions and chest pain (Richter et al.,
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1989). Reflux of stomach acid or bile salts (whose origins are further down
the digestive tract) also presumably produce chest pain, but neither acid
nor bile reflux is necessarily temporally related to chest pain (Johnson,
Winters, Spurling, Chobanian, & Cattau, 1987; Richter et al, 1989). Never-
theless, several symptoms may suggest pain of esophageal origin: (1) pro-
longed pain duration (i.e., lasting several hours), (2) pain that does not
radiate down the arms, (3) meal-related chest pain, or (4) relief with antacids
(Davies, Jones, Rhodes, & Newcombe, 1985). Even these symptoms, how-
ever, may be observed in some cardiac patients.
Importantly, while 50% of GE pain patients have normal coronary
arteries, by implication then as many as 50% of patients also have demon-
strable coronary disease (Katz et al, 1987; Svensson, Stenport, Tibbling, &
Wranne, 1978). This suggestion of high comorbid prevalence may compli-
cate attempts to rule out pain due to "true" cardiac factors. In addition,
the base rates for gastroesophageal disorders in the general population
have not been adequately established, making relational claims about the
high prevalence in chest pain patients, cardiac patients, or other subgroups
problematic. Nevertheless the high comorbidity rate and possible relation-
ship of GE symptoms to psychological constructs may make psychological
treatment relevant regardless of the causal relationship between GE dys-
function and chest pain.
PSYCHIATRIC DISORDERS
Several psychiatric disorders may present with chest pain as the central
symptom. Panic is the most common and thoroughly researched and in-
cludes chest pain as a possible diagnostic indicator (American Psychiatric
Association, 1994). Katon (1984) reports that 89% of panic-disordered
patients referred by primary care physicians for a psychiatric consult initially
presented with somatic complaints (cardiac, gastrointestinal, and neurologic
symptoms, respectively, being the most common). Beitman and colleagues
have studied and written extensively on the topic of chest pain and panic
(e.g., Beitman, 1992; Beitman etal, 1987,1989b, 1991b, Beitman, Kushner,
Lamberti, & Mukerji, 1990). In one study, 58% of nonischemic chest pain
cases met criteria for panic disorder (Beitman et al, 1987). Misdiagnosis
of panic as cardiac in origin can result in unnecessary health service utiliza-
tion and iatrogenic morbidity (Edlund & Swann, 1987; Markowitz, Weiss-
man, Ouellette, Lish, & Klerman, 1989; McCullough, Ayad, O'Neill, &
Goldstein, 1998). Recently, Fraenkel, Kindler, and Melmed (1996/1997)
found that brief assessment of fear-based cognitions could differentiate
panic from ischemic chest pain. However, many of these panic/chest pain
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patients may not report accompanying fear and are not demographically
different from those who do (Beitman et al, 1990).
Somatoform disorders have not been well studied in terms of nonisch-
emic chest pain, but may theoretically present as such. These patients typi-
cally complain of vague and variable symptoms including gastrointestinal,
sexual, and pseudoneurologic symptoms and pain (including chest pain, pal-
pitations, and shortness of breath). Somatoform disorders that are most likely
to present with chest pain include somatization disorder, pain disorder, and
hypochondriasis. Some degree of hypochondriacal concern is present in
nearly all these patients and this is an avenue of research worth pursuing.
Importantly, we have effective treatment technologies for panic and so-
matoform disorders that include psychotherapy and a range of medications.
Cognitive/behavioral (CBT) psychotherapy is perhaps the most effective
treatment for panic (e.g., Barlow & Craske, 1994; Marshall, Pollack, & Otto,
1997) and is based on the premise that via erroneous learning individuals
exhibit anxiety and sympathetic arousal under inappropriate conditions.
Pharmacotherapies may also be warranted in the form of anxiolytics (usually
a high-potency benzodiazepine) or antidepressants (particularly the polycy-
clic antidepressants) (Beitman, 1992). Several studies have reported in-
creased efficacy of in vivo exposure therapies with antidepressants (Mavissa-
kalian & Michelson, 1986; Telch, Agras, Taylor, Roth, & Gallen, 1985).
Importantly, medication may also interfere with CBT (Bouton & Swartzen-
truber, 1991) by negative reinforcement, reducing motivation, impairing
learning, lowering perceived control, or increasing fear upon removal of the
medication (Bouton & Swartzentruber, 1991; Craske & Barlow, 1993; Mar-
shall et al, 1997). In support of the latter, Beitman (1992) reported that up
to 80% of panic disorder individuals relapsed within a few months after medi-
cation is withdrawn. It has been suggested (Marshall et al., 1997) that the
timing and dosage of both psychotherapy and psychopharmacology may in-
fluence outcome. This is clearly another area requiring further empirical
study.
COMORBIDITY
One aspect of this literature that may account for some of the concep-
tual confusion and clinical complexity of chest pain symptoms is the comor-
bidity of various conditions presented here. Probably the most conspicuous
and consistent aspect of the comorbidity literature is the presence of emo-
tional distress across all forms of chest pain. Studies have estimated that
33-46% of nonischemic chest pain patients will meet diagnostic criteria for
panic disorder (Bass et al., 1983; Beitman et al., 1989b; Katon et al., 1988).
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Roy-Byrne et al. (1989) found a 40% incidence rate of comorbid panic
disorder in patients diagnosed with MVA. Their MVA subjects also devel-
oped panic symptoms in response to lactate infusion. While the study sample
was small, these data suggest that sympathetic activation may act as a
common pathway for both MVA and panic, douse and Lustman (1983)
reported that psychiatric disorders (e.g., somatization disorders, anxiety
disorders, and depression) were identified in 21 of 25 patients with distal
esophageal motility abnormalities. Only Ketterer, Kenyon, Foley, Brymer,
Rhoads, Kraft, and Lovallo (1996b) and Beitman et al. (1987) have exam-
ined specifically depressive symptomatology in nonischemic chest pain pa-
tients, but found these patients may also be vulnerable to depression. What
is needed is a conceptual framework that bridges these diverse conditions
and aids psychologists in assessing and treating the psychological and behav-
ioral components of this clinical conundrum.
A COGNITIVE/BEHAVIORAL-PAIN
SELF-MANAGEMENT MODEL
Eifert (1992) and Salkovskis and colleagues (Clark, Salkvoskis, Ost,
Breithholtz, Koehler, Wrestling, Jeavons, & Gelder, 1997; Salkovskis, 1992;
Warwick & Salkovskis, 1990) have provided well-considered cognitive-
behavioral conceptualizations for chest pain of nonischemic origin. Eifert
(1992) refers to the condition as "cardiophobia." In cardiophobics a positive
feedback system develops whereby sympathetically driven cardiac symp-
toms of emotional distress (e.g., tachycardia misinterpreted as angina or a
heart attack) become the focus of somatic attention. Related avoidance
behaviors develop out of negatively reinforced associations with the end
result being repeated avoidance through phobic responding. Salkovskis'
theory and data (i.e., Clark et al., 1997) indicate that inappropriate illness
behavior results from the cognitive misinterpretation of the somatic symp-
toms of anxiety, which in turn reinforce somatic focus and mediate pain
tolerance/threshold. Data suggest that muscle tension in some cases may
be causally related to chest pain, and Lynch et al. (1991) found that increased
chest wall EMG is associated with both somatic and cognitive symptoms
of panic. These data suggest that muscle tension in some cases may be
causally related to chest pain.
Somatosensory amplification is theorized to be a core phenomenon in
hypochondriasis, and may also pertain to chronic chest pain (Barsky, 1979;
Barsky & Wyshak, 1990; Cioffi, 1991; Warwick & Salkovskis, 1990). Somato-
sensory amplification concerns the tendency to amplify interoceptive cues.
Both Efiert and Salkovski also suggest that mislabeling of affective states
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may contribute to maintenance of the system. The exact causes of this
misinterpretation continue to be a matter of investigation and debate.
Misinterpretation may arise from an actual variation in visceral perceptual
sensitivity (e.g., nociception) or by way of some higher cortical function.
An early study by Tyrer, Lee, and Alexander (1980) found that hypochon-
driacal and anxious subjects were better able to predict their own heart
rate reactivity relative to patients with phobic anxiety when exposed to
experimental stress, suggesting increased cardiac focus. Gramling, Clawson,
and McDonald (1996) recently reported that female hypochondriacal sub-
jects manifested greater cardiac reactivity and slower returns to resting
baseline during experimental stress as compared to controls. There is also
support for abnormal nociception (Turiel, Galassi, Glazier, Kaski, & Ma-
seri). This study showed that women with nonischemic chest pain have lower
pain thresholds and tolerance when compared to women with demonstrable
coronary artery disease. Recently Barsky, Orav, Delamater, Clancy, and
Hartley (1998) found that emotionally distressed subjects reported more
cardiopulmonary symptoms at the same level of exercise capacity. Individ-
ual differences in pain threshold/tolerance or cognitive appraisal in these
patients may also account for differential treatment seeking. A cognitive-
behavioral model and somatosensory amplification fit neatly together in a
diathesis stress model. The essential difference in these conceptualizations
lies in the level of CNS processing at which the error occurs. Importantly,
erroneous processing may occur at more than one level of processing in
an escalating positive feedback system.
Psychological conceptualizations and treatments break down when
real risk factors are also present. Specifically, these conceptualizations and
related interventions require patients to reinterpret chest pain symptoms
in a more benign fashion. This could be potentially dangerous if the symp-
toms are cardiac in origin. The implicit requirement is that patients must
balance Type I/Type II error. Given the potentially life-threatening nature
of symptoms, it may be hard to convince patients to accept a Type II error
(i.e., interpret deadly somatic symptoms as benign) when real cardiac risk
factors are present (e.g., family history of heart disease, obesity, stable
angina). We propose a spectrum approach to chest pain that builds on
the theories of Eifert (1992), Salkovskis (1992), and Barsky (1979). This
spectrum approach assumes that there are multiple physiologic pathways for
chest pain (e.g., angina, MVA, chest wall muscle tension). Each represents a
necessary and sufficient condition for chest pain and none are fully indepen-
dent. Bouts of chest pain vary both within patients and between patients
in terms of the relative contribution of psychophysiologic variables. For
heuristic purposes one might consider angina pectoris as anchoring one
endpoint of the spectrum and classic panic disorder as anchoring the other.
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Such a conceptualization has implications for treatment. The entire
spectrum of chest pain patients are likely to benefit from some form
of self-management program where the treatment goals are to minimize
the negative consequences of a chronic condition. Such a program
deemphasizes the notion of a "cure" and instead assists the patient in
developing problem- and emotion-focused strategies for coping and
adjusting to the full range of sequela resulting from chest pain while
optimizing daily functioning. For example, patients with true angina
should interpret their symptoms in terms of feedback relevant to physical
self-pacing to avoid the "sawtooth" pattern of activity seen in most
chronic pain patients. A pure panic patient would be required to interpret
his or her physiology very differently, typically being instructed to
tolerate the discomfort through introceptive exposure techniques. Despite
preliminary evidence for abnormal nociception in nonischemic chest pain,
little pain perception research has been conducted with chest pain.
Indeed, interventions nested in pain self-management programs that
emphasize improved coping strategies, self-pacing, and functional living
goals would seem appropriate for any of the disorders discussed here.
Interestingly, conceptual models and comprehensive treatment programs
for chronic pain (Hanson & Gerber, 1990; Turk, Meichenbaum, & Genest,
1983) have received considerable clinical and research attention, but
have rarely been considered with regard to chest pain.
The efficacy of psychotherapeutic or pharmacologic treatments for
chest pain is only beginning to be substantiated and few treatment outcome
studies on nonischemic chest pain symptoms have been published (Beitman
et al, 1989a; Cannon et al., 1994; Klimes, Mayou, Pearce, Coles, & Fagg,
1990; Levenkron, Goldstein, Adamides, & Greenland, 1985; Pearce,
Mayou, & Klimes, 1990). These data are preliminary, but indicate that both
cognitive/behavioral and psychopharmacologic intervention can reduce
chest pain (frequency and intensity), increase activities of daily living and
reduce utilization of medical services. Both Beitman et al. (1989a) and
Cannon et al. (1994) have evaluated pharmacologic interventions (alprazo-
lam and imipramine, respectively) for nonischemic chest pain. The Beitman
et al. (1989a) study was an unblinded study with a relatively small sample
(N = 20) that demonstrated improved panic symptoms, but only a "margin-
ally significant" improvement in chest pain frequency or intensity. Cannon
et al. (1994) compared imipramine to clonidine in a randomized, double-
blind, placebo-controlled trial on chest pain and found that imipramine
reduced chest pain symptoms regardless of baseline cardiac, esophageal,
or psychiatric status. To date, no study has addressed the issues of additive or
synergistic effects of medication plus therapy, nor have more economically
viable group or brief therapy formats been tested, with one exception.
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Swinson et al (1992) demonstrated that early and brief intervention applied
in the ER (i.e., one session exposure instruction for panic) reduced both
chest pain and other panic symptoms with treatment gains maintained at
6 months when compared to reassurance alone.
SUMMARY
Chest pain symptoms are common across a broad spectrum of health
care settings and can be indicative of any number of conditions ranging
from relatively benign (e.g., a single isolated panic attack) to life-threatening
(e.g., acute myocardial infarction). Misdiagnosis can result in unnecessary
and invasive diagnostic procedures, prolonged use of unnecessary medica-
tions (e.g., nitrates, calcium channel blockers), continued disability, and
unnecessary health services utilization. Because psychological and behav-
ioral variables appear to be common and relevant to the many forms of
chest pain, psychologists will play an increasing role in the assessment and
treatment of chest pain patients. Therefore, it behooves psychologists to
be aware of the complex clinical issues surrounding chest pain symptoms so
they make appropriate clinical decisions regarding referral and treatment.
Table I summarizes the critical diagnostic symptom patterns that should
be considered during a clinical interview when patients present with chest
pain as a central symptom. In such cases the relationship to well-established
cardiac risk factors (i.e., smoking, hypertension, family history, morbid
obesity, diabetes, sedentary lifestyle, hypercholesterolemia) meals, stressful
events, and emotional distress should be evaluated.
Several broad treatment goals should be universally considered. Al-
most all patients would benefit from mastering some form of psychophysio-
logic self-regulation (i.e., controlled breathing, relaxation, biofeedback,
meditation, etc.). Minimally, these interventions should be intended to
circumvent episodes of hyperventilation. Cognitive restructuring may also
be required. The specific nature of restructuring would depend on patient
characteristics, but must keep in mind the Type I/Type II decision these
individuals face with every bout of chest pain. The antecedent conditions
that trigger bouts of chest pain may aid patients in the discrimination
process. Cognitive restructuring may require helping the patient accurately
discriminate subtle psychophysiologic perceptions. Biofeedback (perhaps
used in combination with exercise tolerance protocols) may be particularly
relevant with this discriminative learning process. Patients prone to amplifi-
cation may benefit from biofeedback that can help them either better
control cardiovascular reactivity or provide them with concrete data regard-
ing the benign relationship between their physiologic functioning, the physi-
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cal symptoms, and their cognitive/emotional experience. Emotional distress
can also be addressed with models for depression (Beck, Rush, Shaw, &
Emory, 1979), panic (Barlow & Craske, 1994), or rational emotive therapy
(Walen, DiGiuseppe, & Wessler, 1992) used singly or in combination.
What appears to be clear is that if appropriate treatment is not available,
these patients will continue to experience increased morbidity, disability,
and unnecessary medical system utilization (Bass et al., 1983; Lantinga
et al, 1988; Ockene et al., 1980; Papanicolaou et al., 1986; Romeo,
Rosano, Martuscelli, Lombardo, & Valente, 1993; Swinson & Kuch,
1990; Wielgosz et al., 1984).
Despite a growing literature, much remains unknown about nonisch-
emic forms of chest pain. The issue of comorbidity is one that has contrib-
uted to confusion, and differences in symptom cluster warrants further
investigation. Better epidemiologic data on the cooccurrence of the various
conditions discussed here may have important implications for treatment
development, understanding utilization patterns, and identification of com-
mon psychophysiologic pathways. For example, research is needed to iden-
tify variables that differentiate panic-masked cardiac cases from those that
are more appropriately "captured" by mental health services. Little is
known about those panic cases that fall outside of mental health catchment
or undergo invasive forms of diagnostic testing. Research assessing patterns
of utilization in various clinical settings (e.g., emergency rooms, catheteriza-
tion labs, primary care, mental health) would be very helpful in devising
optimal triaging/treatment protocols. Treatment outcome studies have only
recently been published. Given that emotional distress (e.g., depression,
panic, generalized and specific phobia) is the one consistent aspect of this
otherwise heterogeneous population, one dilemma is devising appropriate
psychotherapeutic interventions to help patients with both panic and real
cardiovascular risk factors better discriminate their symptoms so as to seek
treatment appropriately. Understanding the underlying psychophysiology
and individual differences of chest pain patients would support the develop-
ment of cognitive-behavioral and psychophysiologic interventions. The data
on somatosensory amplification and abnormal nociception hold promise in
this regard. Interestingly, many of these patients present with hypochondri-
cal cognitive and behavioral characteristics, yet this diagnosis has never
been thoroughly applied to nonischemic chest pain. An additional treatment
challenge will be creating efficient and effective treatments (both psycho-
therapeutic and psychopharmacologic) that target patients at critical entry
points in the health care system. Finally, further research addressing indirect
costs and quality-of-life measures in the context of treatment outcome
studies of chest pain with panic would also help broaden our understanding
of continued disability in these patients.
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